Literature DB >> 16319751

Pathomechanism of ligamentum flavum hypertrophy: a multidisciplinary investigation based on clinical, biomechanical, histologic, and biologic assessments.

Koichi Sairyo1, Ashok Biyani, Vijay Goel, Douglas Leaman, Robert Booth, Jean Thomas, Daniel Gehling, Lakshmi Vishnubhotla, Rebecca Long, Nabil Ebraheim.   

Abstract

STUDY
DESIGN: A multidisciplinary study involving clinical, histologic, biomechanical, biologic, and immunohistologic approaches. OBJECTIVE.: To clarify the pathomechanism of hypertrophy of the ligamentum flavum. SUMMARY OF BACKGROUND DATA: The most common spinal disorder in elderly patients is lumbar spinal canal stenosis, causing low back and leg pain, and paresis. Canal narrowing, in part, results from hypertrophy of the ligamentum flavum. Although histologic and biologic literature on this topic is available, the pathomechanism of ligamentum flavum hypertrophy is still unknown.
METHODS: The thickness of 308 ligamenta flava at L2/3, L3/4, L4/5, and L5/S1 levels of 77 patients was measured using magnetic resonance imaging. The relationships between thickness, age, and level were evaluated. Histologic evaluation was performed on 20 ligamentum flavum samples, which were collected during surgery. Trichrome and Verhoeff-van Gieson elastic stains were performed for each ligamentum flavum to understand the degree of fibrosis and elastic fiber status, respectively. To understand the mechanical stresses in various layers of ligamentum flavum, a 3-dimensional finite element model was used. Von Mises stresses were computed, and values between dural and dorsal layers were compared. There were 10 ligamenta flava collected for biologic assessment. Using real-time reverse transcriptase polymerase chain reaction, transforming growth factor (TGF)-beta messenger ribonucleic acid expression was quantitatively measured. The cellular location of TGF-beta was also confirmed from 18 ligamenta flava using immunohistologic techniques.
RESULTS: The ligamentum flavum thickness increased with age, however, the increment at L4/5 and L3/4 levels was larger than at L2/3 and L5/S1 levels. Histology showed that as the ligamentum flavum thickness increased, fibrosis increased and elastic fibers decreased. This tendency was more predominant along the dorsal side. Von Misses stresses revealed that the dorsal fibers of ligamentum flavum were subjected to higher stress than the dural fibers. This was most remarkably observed at L4/5. The largest increase in ratio observed between the dorsal and dural layer was approximately 5-fold in flexion at L4/5 in flexion. Expression of TGF-beta was observed in all ligamenta flava, however, the expression decreased as the ligamentum flavum thickness increased. Immunohistochemistry showed that TGF-beta was released by the endothelial cells, not by fibroblasts.
CONCLUSIONS: Fibrosis is the main cause of ligamentum flavum hypertrophy, and fibrosis is caused by the accumulation of mechanical stress with the aging process, especially along the dorsal aspect of the ligamentum flavum. TGF-beta released by the endothelial cells may stimulate fibrosis, especially during the early phase of hypertrophy.

Entities:  

Mesh:

Year:  2005        PMID: 16319751     DOI: 10.1097/01.brs.0000188117.77657.ee

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  60 in total

1.  Three dimensional finite element analysis of the pediatric lumbar spine. Part II: biomechanical change as the initiating factor for pediatric isthmic spondylolisthesis at the growth plate.

Authors:  Koichi Sairyo; Vijay K Goel; Akiyoshi Masuda; Srilakshmi Vishnubhotla; Ahmad Faizan; Ashok Biyani; Nabil Ebraheim; Daisuke Yonekura; Ri-Ichi Murakami; Tomoya Terai
Journal:  Eur Spine J       Date:  2006-04-14       Impact factor: 3.134

2.  Lumbar spinal stenosis in a young individual as a result of ligamantum flavum ossification: A case report.

Authors:  Murat Yilmaz; Orhan Kalemci; Hakan Yilmaz; Necdet M Palaz
Journal:  Int J Surg Case Rep       Date:  2013-05-09

3.  Thickness of the ligamentum flavum: correlation with age and its asymmetry-an magnetic resonance imaging study.

Authors:  Vrushali Subhash Kolte; Seema Khambatta; Medha Vijay Ambiye
Journal:  Asian Spine J       Date:  2015-04-15

4.  Myofibroblast in the ligamentum flavum hypertrophic activity.

Authors:  Junseok W Hur; Taegeun Bae; Sunghyeok Ye; Joo-Hyun Kim; Sunhye Lee; Kyoungmi Kim; Seung-Hwan Lee; Jin-Soo Kim; Jang-Bo Lee; Tai-Hyoung Cho; Jung-Yul Park; Junho K Hur
Journal:  Eur Spine J       Date:  2017-02-08       Impact factor: 3.134

5.  Clinically significant radiographic parameter for thoracic myelopathy caused by ossification of the ligamentum flavum.

Authors:  Byung-Jou Lee; Jin Hoon Park; Sang-Ryong Jeon; Seung-Chul Rhim; Sung Woo Roh
Journal:  Eur Spine J       Date:  2018-09-06       Impact factor: 3.134

6.  Clinical symptoms of lumbar spinal stenosis associated with morphological parameters on magnetic resonance images.

Authors:  Young Uk Kim; Yu-Gyeong Kong; Jonghyuk Lee; Yuseon Cheong; Se hun Kim; Hyun Kyu Kim; Jun Young Park; Jeong Hun Suh
Journal:  Eur Spine J       Date:  2015-08-21       Impact factor: 3.134

7.  Interspinous posterior devices: What is the real surgical indication?

Authors:  Alessandro Landi
Journal:  World J Clin Cases       Date:  2014-09-16       Impact factor: 1.337

Review 8.  [Lumbar spinal stenosis].

Authors:  T L Schulte; V Bullmann; T Lerner; M Schneider; B Marquardt; U Liljenqvist; T A Pietilä; L Hackenberg
Journal:  Orthopade       Date:  2006-06       Impact factor: 1.087

9.  Degenerative lumbar spinal stenosis and lumbar spine configuration.

Authors:  J Abbas; K Hamoud; H May; O Hay; B Medlej; Y Masharawi; N Peled; I Hershkovitz
Journal:  Eur Spine J       Date:  2010-07-21       Impact factor: 3.134

Review 10.  Lumbar spinal stenosis: syndrome, diagnostics and treatment.

Authors:  Eberhard Siebert; Harald Prüss; Randolf Klingebiel; Vieri Failli; Karl M Einhäupl; Jan M Schwab
Journal:  Nat Rev Neurol       Date:  2009-07       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.